should one doctor attend London NASH congress - I listened to several podcasts at the Global London NASH Congress - and there was no mention of leronlimab when discussing all the clinical trials - this meeting is in person only and allows face to face discussions between doctors -- can someone confirm we have someone from the Scientific Advisors board will be sitting in the round tables there?
My two cents says we lack representation or simple awareness that perhaps lessor contributors are getting exposure while no Doctor hear about Leronlimab for NASH
This I fear - but we can chip in to buy a round trip London ticket for even a non-essential CYDY science aadvisor to attend? Better than nothing?